SCHEMBL10949068

SCHEMBL10949068

CCCCCCCCC([C]=O)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.36
MAPT P10636 1/20 0.34
SMPD1 P17405 3/20 0.33
FDPS P14324 4/20 0.32
ZDHHC7 Q9NXF8 1/20 0.32
GPR84 Q9NQS5 3/20 0.32
FFAR1 O14842 1/20 0.32
LCK P06239 1/20 0.31
PPARD Q03181 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31
LMNA P02545 1/20 0.31
GRIK1 P39086 1/20 0.30
GRIK2 Q13002 1/20 0.30
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH4 P08319 1/20 0.30
ADH7 P40394 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9794085 0.83 CA2 (0.33) CA2LMNA
SCHEMBL16644725 0.83 CA2 (0.33) CA2LMNA
SCHEMBL9794156 0.83 CA2 (0.33) CA2LMNA
SCHEMBL9794153 0.83 CA2 (0.33) CA2LMNA
SCHEMBL1667055 0.83 CA2 (0.33) CA2LMNA
SCHEMBL31682129 0.83 CA2 (0.33) CA2LMNA
SCHEMBL31682159 0.83 CA2 (0.33) CA2LMNA
SCHEMBL31682138 0.83 CA2 (0.33) CA2LMNA
SCHEMBL9794169 0.83 CA2 (0.33) CA2LMNA
SCHEMBL9794171 0.83 CA2 (0.33) CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0100900-B1 NOVEL (3.2.0.) BICYCLOHEPTANONE OXIME ETHERS WITH VALUABLE THERAPEUTIC PROPERTIES SYNTEX (U.S.A.) INC. (US) 1986-02-05 EP disclosed
US-4552898-A CARDIOVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-11-12 US disclosed
EP-0100900-A1 Novel (3.2.0.) bicycloheptanone oxime ethers with valuable therapeutic properties SYNTEX (U.S.A.) INC. (US) 1984-02-22 EP disclosed